Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMMUNE GLOBULIN NOS: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

54.2%
Female
45.8%
Male

Age Information

The average age of patients reporting adverse events with IMMUNE GLOBULIN NOS is 40.1 years.

Geographic Distribution

The majority of adverse event reports for IMMUNE GLOBULIN NOS originate from US.

Report Summary & Outcomes

2,251
Total Reports
2,251
As Primary/Secondary Suspect
428
Deaths Reported
1,046
Hospitalizations
303
Life-Threatening
21
Disabilities

Reporting Timeline

First adverse event report: 19991201. Most recent report: 20250511. View full timeline →

More About IMMUNE GLOBULIN NOS

IMMUNE GLOBULIN NOS Full Profile Reports by Year Drug Interactions